Ryo Funayama
Impact in
- Biological Psychiatry top 5%
- Molecular Biology top 5%
- Genomics, phytochemicals, and oxidative stress
- Epigenetics and DNA Methylation
- Glutathione Transferases and Polymorphisms
- Genomics and Chromatin Dynamics
- RNA modifications and cancer
Papers in
-
- Epigenetics and DNA Methylation 12
- RNA modifications and cancer 7
- Ubiquitin and proteasome pathways 5
- Genomics and Chromatin Dynamics 4
- Genetics 13
- Genetics and Neurodevelopmental Disorders 6
- Co-authors
- Keiko Nakayama (68 shared papers)Takeshi Nagashima (20 shared papers)Masayuki Yamamoto (4 shared papers)Eri Kobayashi (3 shared papers)Takafumi Suzuki (2 shared papers)Makiko Hayashi (1 shared paper)Nobuyuki Tanaka (1 shared paper)Takashi Moriguchi (1 shared paper)
- Journals
- Cancer Science (5 papers)Brain and Development (4 papers)Cell Reports (4 papers)PLoS ONE (3 papers)The Journal of Immunology (3 papers)
- Partner nations
- JapanUnited StatesCanada
In The Last Decade
Ryo Funayama
71 papers receiving 4.1k citations
Ryo Funayama's Hit Papers
Peers
Comparison fields: 5 of 121
- Biological Psychiatry 90
- Molecular Biology 2.3k
- Immunology 677
- Cancer Research 392
- Aging 41
Countries citing papers authored by Ryo Funayama
This map shows the geographic impact of Ryo Funayama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryo Funayama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryo Funayama more than expected).
Fields of papers citing papers by Ryo Funayama
This network shows the impact of papers produced by Ryo Funayama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryo Funayama. The network helps show where Ryo Funayama may publish in the future.
Co-authors
The 25 scholars most cited alongside Ryo Funayama, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 73 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Nrf2 suppresses macrophage inflammatory response by blocking proinflammatory cytokine transcription Hit paper breakdown → | 2016 | 1460 |
| 2 | 2012 | 351 | |
| 3 | 2016 | 214 | |
| 4 | 2006 | 172 | |
| 5 | 2007 | 118 | |
| 6 | 2011 | 92 | |
| 7 | 2020 | 83 | |
| 8 | 2015 | 77 | |
| 9 | 2013 | 72 | |
| 10 | 2016 | 72 | |
| 11 | 2019 | 68 | |
| 12 | 2018 | 57 | |
| 13 | 2013 | 56 | |
| 14 | 2016 | 55 | |
| 15 | 2016 | 49 | |
| 16 | 2012 | 46 | |
| 17 | 2019 | 46 | |
| 18 | 2014 | 45 | |
| 19 | 2015 | 43 | |
| 20 | 2014 | 43 |
About Ryo Funayama
Ryo Funayama is a scholar working on Molecular Biology, Genetics, Immunology, Oncology and Physiology, having authored 73 papers that have together received 4.1k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (12 papers), RNA modifications and cancer (7 papers), Genetics and Neurodevelopmental Disorders (6 papers), Ubiquitin and proteasome pathways (5 papers), Cell Adhesion Molecules Research (5 papers), Genomics and Chromatin Dynamics (4 papers), Telomeres, Telomerase, and Senescence (4 papers) and Immune Cell Function and Interaction (4 papers). The work is most often cited by research in Biological Psychiatry (90 citations), Molecular Biology (2.3k citations), Immunology (677 citations), Cancer Research (392 citations) and Aging (41 citations). Ryo Funayama has collaborated with scholars based in Japan, United States and Canada. Frequent co-authors include Keiko Nakayama, Takeshi Nagashima, Masayuki Yamamoto, Eri Kobayashi, Takafumi Suzuki, Makiko Hayashi, Nobuyuki Tanaka, Takashi Moriguchi, Hozumi Motohashi and Hiroki Sekine. Their work appears in journals such as Cancer Science, Brain and Development, Cell Reports, PLoS ONE and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.